- 12 August
-
Experts from the Russian Ministry of Health have included the TRIAZAVIRIN® antiviral drug in the guidelines «Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection COVID-19» (version No. 19 dated 27/5/2025).
- 17 June
-
From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
- 13 June
-
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.
- 10 June
-
In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.
- Home
- Cluster members
- Ural instrument-engineering plant JSC
Ural instrument-engineering plant JSC
URAL INSTRUMENT-ENGINEERING PLANT JSC (UIMP JSC, part of Concern Radio-cum-Electronic Technologies JSC (KRET) of the Rostec State Corporation) is a manufacturer of competitive medical equipment and a participant in state programs for the development of the radio-electronic industry. The company has a research and development center (R&D center), which is involved in the implementation of promising research, development and technology, market analysis and development of innovative solutions in the field of medical device industry.
Description of medical products:
Artificial lung ventilation device Mobivent
A high-end turbine-driven device for stationary use, as well as for patient transportation, within professional healthcare facilities.
Equipped with a display with adjustable tilt angle, graphical interface, advanced element base and a wide range of ventilation modes, special functions and additional options. Designed for patients weighing from 2 to 300 kg.
Artificial lung ventilation device Mobivent OKSI
A compact solution for high-flow oxygen therapy in adult and pediatric patients, with a built-in humidification system for intensive care of independently breathing adults and children, in inpatient treatment for conditions requiring an intensive flow of heated and humidified breathing oxygen-air mixture.
Transport artificial lung ventilation device Mobivent ARM
A device for transporting patients (adults and children, weighing from 2 to 300 kg) by ambulances, aircraft, inside healthcare facilities, as well as in operating rooms and intensive care units.
Compact size 6.5 kg, 8-inch color touch display, high turbine performance and autonomous operation up to 10 hours.
Central Monitoring Station (CMS)
A modern digital system for centralized monitoring, collection and processing of patient's vital parameters data from bedside medical equipment by a wide range of manufacturers and of various types:
Artificial lung ventilation devices
Anesthesia and respiratory devices
Patient monitors
Syringe and volumetric pumps
Contacts of the enterprise – 25 km of the Chelyabinsk Tract, Sysert District, Sverdlovsk Region, 624005. Tel: 8 (800) 222-58-40, e- mail: mail@upz.ru, www.upz.ru.
